Triomics

San Francisco, United States

Triomics is a generative AI-powered platform that matches patients to clinical trials.

May 2026

Series B

Top Investors

General CatalystLightspeed Venture PartnersNexus Venture PartnersY CombinatorBattery Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Triomics's investors?

Triomics's investors include General Catalyst, Lightspeed Venture Partners, Nexus Venture Partners, Y Combinator, Battery Ventures.

Where is Triomics headquartered?

Triomics is headquartered in San Francisco, United States.

What does Triomics do?

Triomics is a generative AI-powered platform that matches patients to clinical trials.

What stage is Triomics at?

Triomics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 27, 2026.

MLA

"Triomics — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/triomics. Accessed June 3, 2026.

APA

VCBacked. (2026). Triomics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/triomics

Wikipedia (cite web)

{{cite web |title=Triomics — Funding & Investors |url=https://www.vcbacked.co/company/triomics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 27, 2026.